Your browser doesn't support javascript.
loading
A Cellular Ground Truth to Develop MRI Signatures in Glioma Models by Correlative Light Sheet Microscopy and Atlas-Based Coregistration.
Schregel, Katharina; Heinz, Lennart; Hunger, Jessica; Pan, Chenchen; Bode, Julia; Fischer, Manuel; Sturm, Volker; Venkataramani, Varun; Karimian-Jazi, Kianush; Agardy, Dennis A; Streibel, Yannik; Zerelles, Roland; Wick, Wolfgang; Heiland, Sabine; Bunse, Theresa; Tews, Björn; Platten, Michael; Winkler, Frank; Bendszus, Martin; Breckwoldt, Michael O.
Afiliação
  • Schregel K; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany michael.breckwoldt@med.uni-heidelberg.de katharina.schregel@med.uni-heidelberg.de.
  • Heinz L; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Hunger J; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Pan C; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Bode J; Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Fischer M; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Sturm V; Department of Neurology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Venkataramani V; Molecular Mechanisms of Tumor Invasion, Schaller Research Group at the University of Heidelberg and the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Karimian-Jazi K; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Agardy DA; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Streibel Y; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Zerelles R; Department of Neurology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Wick W; Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Heiland S; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Bunse T; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Tews B; Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Platten M; Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, 68167 Mannheim, Germany.
  • Winkler F; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Bendszus M; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Breckwoldt MO; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
J Neurosci ; 43(30): 5574-5587, 2023 07 26.
Article em En | MEDLINE | ID: mdl-37429718
Glioblastoma is the most common malignant primary brain tumor with poor overall survival. Magnetic resonance imaging (MRI) is the main imaging modality for glioblastoma but has inherent shortcomings. The molecular and cellular basis of MR signals is incompletely understood. We established a ground truth-based image analysis platform to coregister MRI and light sheet microscopy (LSM) data to each other and to an anatomic reference atlas for quantification of 20 predefined anatomic subregions. Our pipeline also includes a segmentation and quantification approach for single myeloid cells in entire LSM datasets. This method was applied to three preclinical glioma models in male and female mice (GL261, U87MG, and S24), which exhibit different key features of the human glioma. Multiparametric MR data including T2-weighted sequences, diffusion tensor imaging, T2 and T2* relaxometry were acquired. Following tissue clearing, LSM focused on the analysis of tumor cell density, microvasculature, and innate immune cell infiltration. Correlated analysis revealed differences in quantitative MRI metrics between the tumor-bearing and the contralateral hemisphere. LSM identified tumor subregions that differed in their MRI characteristics, indicating tumor heterogeneity. Interestingly, MRI signatures, defined as unique combinations of different MRI parameters, differed greatly between the models. The direct correlation of MRI and LSM allows an in-depth characterization of preclinical glioma and can be used to decipher the structural, cellular, and, likely, molecular basis of tumoral MRI biomarkers. Our approach may be applied in other preclinical brain tumor or neurologic disease models, and the derived MRI signatures could ultimately inform image interpretation in a clinical setting.SIGNIFICANCE STATEMENT We established a histologic ground truth-based approach for MR image analyses and tested this method in three preclinical glioma models exhibiting different features of glioblastoma. Coregistration of light sheet microscopy to MRI allowed for an evaluation of quantitative MRI data in histologically distinct tumor subregions. Coregistration to a mouse brain atlas enabled a regional comparison of MRI parameters with a histologically informed interpretation of the results. Our approach is transferable to other preclinical models of brain tumors and further neurologic disorders. The method can be used to decipher the structural, cellular, and molecular basis of MRI signal characteristics. Ultimately, information derived from such analyses could strengthen the neuroradiological evaluation of glioblastoma as they enhance the interpretation of MRI data.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article